| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 995.73B | 990.41B | 964.09B | 933.11B | 802.85B | 718.01B |
| Gross Profit | 173.31B | 174.75B | 165.65B | 167.02B | 151.10B | 126.65B |
| EBITDA | 70.24B | 68.00B | 59.62B | 79.92B | 80.26B | 53.71B |
| Net Income | 34.57B | 37.84B | -29.81B | 11.47B | 22.96B | -3.84B |
Balance Sheet | ||||||
| Total Assets | 705.09B | 740.72B | 753.99B | 737.00B | 743.52B | 694.28B |
| Cash, Cash Equivalents and Short-Term Investments | 116.06B | 147.94B | 122.67B | 84.17B | 139.73B | 153.07B |
| Total Debt | 73.25B | 101.09B | 129.60B | 122.28B | 121.17B | 123.52B |
| Total Liabilities | 303.32B | 325.20B | 361.16B | 337.21B | 318.21B | 315.90B |
| Stockholders Equity | 400.32B | 414.00B | 391.18B | 398.22B | 389.61B | 345.13B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 22.78B | 41.83B | -28.36B | -4.88B | 11.16B |
| Operating Cash Flow | 0.00 | 65.82B | 89.17B | 15.41B | 34.30B | 42.64B |
| Investing Cash Flow | 0.00 | -1.68B | -55.09B | -54.20B | -45.51B | -41.16B |
| Financing Cash Flow | 0.00 | -37.30B | -1.81B | -742.00M | -13.54B | 14.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥431.95B | 9.21 | 11.96% | 3.04% | 2.70% | ― | |
78 Outperform | ¥708.87B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
74 Outperform | ¥6.75T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
67 Neutral | ¥3.97T | 15.03 | ― | 1.41% | 7.73% | -1.93% | |
64 Neutral | ¥161.94B | 29.59 | 5.91% | 2.39% | -3.24% | -25.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
56 Neutral | ¥515.91B | 15.62 | ― | 2.57% | 4.81% | -49.43% |